Substrate analogs that substitute for lipid I as a substrate for MurG
US6413732B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Feb 2, 1999 |
| Grant date | Jul 2, 2002 |
| Priority date | — |
| Expiry date | Feb 2, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/812
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
General methods for monitoring the activity of MurG, a GlcNAc transferase involved in bacterial cell wall biosynthesis, is disclosed. More particularly, the synthesis of simplified substrate analogs of Lipid I (the natural substrate for MurG), which function as acceptors for UDP-GlcNAc in an enzymatic reaction catalyzed by MurG, is described. Assays using the substrate analogs of the invention are further disclosed, which are useful for identifying a variety of other substrates, including inhibitors of MurG activity, for facilitating mechanistic and/or structural studies of the enzyme and for other uses. High throughput assays are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.